These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3875055)

  • 21. Acute effects of a parkinsonism-inducing neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on mouse body temperature.
    Satoh N; Yonezawa A; Tadano T; Kisara K; Arai Y; Kinemuchi H
    Life Sci; 1987 Sep; 41(11):1415-24. PubMed ID: 3498107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-Phenylpyridine (4PP) and MPTP: the relationship between striatal MPP+ concentrations and neurotoxicity.
    Irwin I; Langston JW; DeLanney LE
    Life Sci; 1987 Feb; 40(8):731-40. PubMed ID: 3492652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenylpyridinium.
    Vyas I; Heikkila RE; Nicklas WJ
    J Neurochem; 1986 May; 46(5):1501-7. PubMed ID: 3485701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astrocytes convert the parkinsonism inducing neurotoxin, MPTP, to its active metabolite, MPP+.
    Ransom BR; Kunis DM; Irwin I; Langston JW
    Neurosci Lett; 1987 Apr; 75(3):323-8. PubMed ID: 3495754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The histological effects of intracerebral injection or infusion of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and MPP+ (1-methyl-4-phenylpyridinium) in rat and mouse.
    Gibb WR; Costall B; Domeney AM; Kelly ME; Naylor RJ
    Brain Res; 1988 Oct; 461(2):361-6. PubMed ID: 3263168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Region-specific attenuation of a trypsin-like protease in substantia nigra following dopaminergic neurotoxicity by 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine.
    Usha R; Muralikrishnan D; Thomas B; Ghosh S; Mandal C; Mohanakumar KP
    Brain Res; 2000 Nov; 882(1-2):191-5. PubMed ID: 11056198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on presynaptic dopamine uptake sites in the mouse striatum.
    Donnan GA; Kaczmarczyk SJ; Rowe PJ; Figdor R; Mendelsohn FA
    J Neurol Sci; 1986 Jun; 74(1):111-9. PubMed ID: 3487620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) selectively destroys dopaminergic neurons in cultures of dissociated rat mesencephalic neurons.
    Sanchez-Ramos J; Barrett JN; Goldstein M; Weiner WJ; Hefti F
    Neurosci Lett; 1986 Dec; 72(2):215-20. PubMed ID: 2880321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain.
    Mizuno Y; Sone N; Saitoh T
    J Neurochem; 1987 Jun; 48(6):1787-93. PubMed ID: 3106573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depletion of norepinephrine in mouse heart by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mimicked by 1-methyl-4-phenylpyridinium (MPP+) and not blocked by deprenyl.
    Fuller RW; Hemrick-Luecke SK
    Life Sci; 1986 Nov; 39(18):1645-50. PubMed ID: 3095601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
    Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
    Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine metabolism and 1-methyl-4-phenylpyridinium uptake in dissociated cell cultures from the embryonic mesencephalon.
    Schinelli S; Zuddas A; Kopin IJ; Barker JL; di Porzio U
    J Neurochem; 1988 Jun; 50(6):1900-7. PubMed ID: 3259619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 1-Methyl-4-phenylpyridinium (MPP+) but not 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) serves as methyl donor for dopamine: a possible mechanism of action.
    Charlton CG
    J Geriatr Psychiatry Neurol; 1992; 5(2):114-8. PubMed ID: 1590912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
    Clarke PB; Reuben M
    Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
    Ito T; Suzuki K; Uchida K; Nakayama H
    Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
    Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion in brain tissue by gas chromatography/mass spectrometry.
    Shih MC; Markey SP
    Biomed Environ Mass Spectrom; 1986 Feb; 13(2):85-9. PubMed ID: 2937483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its main metabolite 1-methyl-4-phenylpyridinium ion (MPP+) in the rat.
    Algeri S; Ambrosio S; Garofalo P; Gerli P
    Eur J Pharmacol; 1987 Sep; 141(2):309-12. PubMed ID: 3500067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats.
    Sonsalla PK; Zeevalk GD; Manzino L; Giovanni A; Nicklas WJ
    J Neurochem; 1992 May; 58(5):1979-982. PubMed ID: 1560247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.